Abstract
Andrew J. Bradley (Quality Milk Management Services Ltd., Somerset, United Kingdom; and University of Nottingham, School of Veterinary Medicine and Science, Sutton Bonington, United Kingdom) was erroneously omitted as a co-author of this article. All authors agree to his addition as an author. The authors regret the error. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: Development of interpretive criteria for testing by broth microdilution and disk diffusionJournal of Dairy ScienceVol. 97Issue 10PreviewDry cow therapy is an important part of mastitis control. This therapy typically consists of an antibiotic or antibiotics administered at a single dose by intramammary infusion at dry off to treat or prevent infection by prevalent mastitis pathogens. A combination dry cow therapy consisting of the active components penicillin and framycetin is currently used in several countries. Despite its use, standardized methods for the susceptibility testing of this combination against mastitis pathogens have not been established. Full-Text PDF Open Archive
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.